Article
FDA advisers narrowly back first gene therapy for muscular dystrophy
Rating:
0.0
Views:
59
Likes:
1
Library:
1
A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value